A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma

BACKGROUND: A phase II study was performed to investigate the safety and efficacy of weekly doses of combined paclitaxel and 5-fluorouracil (5-FU) with concurrent radiation therapy, followed by 2 cycles of consolidation chemotherapy to treat patients with advanced oesophageal carcinoma. METHODS: The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Xia, Yi, Li, Yun-hai, Chen, Yun, Zhang, Jun-hua, Liu, Qi, Deng, Jia-ying, Ai, Ta-shan, Zhu, Han-ting, Fan, Jian-hong, Badakhshi, Harun, Zhao, Kuai-le
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341476/
https://ncbi.nlm.nih.gov/pubmed/28270162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0785-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados